- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03341650
High Pasta vs. Low Pasta Diet in the Treatment of Obesity
May 3, 2018 updated by: Francesca Scazzina Ph.D., University of Parma
The Effect of High Pasta vs. Low Pasta Mediterranean Diet on Weight Loss in the Treatment of Obese Patients
To the best of our knowledge, the effect of pasta consumption within a hypocaloric Mediterranean diet has only been scarcely explored yet.
Therefore, a two-parallel group dietary intervention was carried out to investigate if pasta consumption could affect the BMI change in obese patients.
The primary outcome was the loss of at leat 8% of the initial body weight in the first 6 months.
Anthropometric and body composition (from bioelectrical impedance analysis - BIA-) measures were collected every month for the first 6 months and after 1 year.
In addition, dietary information was collected at baseline and after 3, 6 and 12 months through a 7-day carbohydrate food record and a 24-h food recall.
Blood samples were collected at baseline and at 6 and 12 months to assess: glucose, insulin, Homeostatic model assessment for insulin resistant (HOMA-IR) index, total cholesterol, low-density lipoprotein, high-density lipoprotein, and uric acid.
Furthermore, the perceived quality of life was investigated through the 36-items short form health survey (SF36) questionnaire.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Parma, Italy, 43125
- Department of Food and Drug, University of Parma
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI between 30-45 kg/m2
- healthy subjects
- regular meal consumption
- no celiac disease
- no menopause woman
Exclusion Criteria:
- with a BMI <30 or >45 kg/m2
- having diabetes, hepatic or kidney diseases
- having an eating disorder
- having celiac disease
- menopause woman
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Pasta
Habitual pasta consumption equal or higher than 5 times/week.
|
Participants received a personalised diet program considering their food preferences and eating behaviour, based on the Italian guidelines for a healthy and Mediterranean diet and were encouraged to maintain their habitual consumption of pasta (at least 5 times/week).
To encourage participants to prepare healthy meals by using high-quality ingredients, participants were provided with a recipe book and dietary guidelines and recommendations.
|
|
Experimental: Low Pasta
Habitual pasta consumption equal or lower than 3 times/week.
|
Participants received a personalised diet program considering their food preferences and eating behaviour, based on the Italian guidelines for a healthy and Mediterranean diet and were encouraged to maintain their habitual consumption of pasta (no more than 3 times/week).
To encourage participants to prepare healthy meals by using high-quality ingredients, participants were provided with a recipe book and dietary guidelines and recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline Body weight at 6 months
Time Frame: baseline, 6 months
|
Measured in kg according to the standard procedure
|
baseline, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline Body weight at 3 months
Time Frame: baseline, 3 months
|
Measured in kg according to the standard procedure
|
baseline, 3 months
|
|
Change from baseline Body weight at 12 months
Time Frame: baseline, 12 months
|
Measured in kg according to the standard procedure
|
baseline, 12 months
|
|
BMI
Time Frame: baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
|
Calculated as body weight in kilograms divided by the square of the height in meters
|
baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
|
|
Waist circumference
Time Frame: baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
|
Measured in cm according to the standard procedure
|
baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
|
|
Free Fat Mass
Time Frame: baseline, 3 months, 6 months, 12 months
|
Estimated by bioelectrical impedance analysis in kg and in %
|
baseline, 3 months, 6 months, 12 months
|
|
Fat Mass
Time Frame: baseline, 3 months, 6 months, 12 months
|
Estimated by bioelectrical impedance analysis in kg and in %
|
baseline, 3 months, 6 months, 12 months
|
|
Basal Metabolic Rate
Time Frame: baseline, 3 months, 6 months, 12 months
|
Estimated by bioelectrical impedance analysis in kcal/day
|
baseline, 3 months, 6 months, 12 months
|
|
Glucose
Time Frame: baseline, 6 months, 12 months
|
mg/dL in fasting condition
|
baseline, 6 months, 12 months
|
|
Insulin
Time Frame: baseline, 6 months, 12 months
|
microU/mL in fasting condition
|
baseline, 6 months, 12 months
|
|
HOMA-IR index
Time Frame: baseline, 6 months, 12 months
|
calculated from glucose and insulin in fasting condition
|
baseline, 6 months, 12 months
|
|
Total cholesterol
Time Frame: baseline, 6 months, 12 months
|
mg/dL in fasting condition
|
baseline, 6 months, 12 months
|
|
HDL cholesterol
Time Frame: baseline, 6 months, 12 months
|
mg/dL in fasting condition
|
baseline, 6 months, 12 months
|
|
LDL cholesterol
Time Frame: baseline, 6 months, 12 months
|
mg/dL in fasting condition
|
baseline, 6 months, 12 months
|
|
Triglycerides
Time Frame: baseline, 6 months, 12 months
|
mg/dL in fasting condition
|
baseline, 6 months, 12 months
|
|
Uric Acid
Time Frame: baseline, 6 months, 12 months
|
mg/dL in fasting condition
|
baseline, 6 months, 12 months
|
|
Energy intake
Time Frame: baseline, 3 months, 6 months, 12 months
|
assessed by a 24-h dietary recall as kcal/day
|
baseline, 3 months, 6 months, 12 months
|
|
Nutrient intakes
Time Frame: baseline, 3 months, 6 months, 12 months
|
assessed by a 24-h dietary recall as g/day
|
baseline, 3 months, 6 months, 12 months
|
|
Carbohydrate-based food intakes
Time Frame: baseline, 3 months, 6 months, 12 months
|
assessed by a 7-day food diary as times/week
|
baseline, 3 months, 6 months, 12 months
|
|
Perceived Quality of Life
Time Frame: baseline, 3 months, 6 months, 12 months
|
assessed by the SF36 questionnaire
|
baseline, 3 months, 6 months, 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Elisabetta Dall'Aglio, MD, University of Parma
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 2, 2015
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
November 7, 2017
First Submitted That Met QC Criteria
November 13, 2017
First Posted (Actual)
November 14, 2017
Study Record Updates
Last Update Posted (Actual)
May 4, 2018
Last Update Submitted That Met QC Criteria
May 3, 2018
Last Verified
November 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SP2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diet Therapy
-
National Institutes of Health Clinical Center (CC)CompletedDiet TherapyUnited States
-
San Raffaele Telematic UniversityCompletedPhysical Activity | Diet Therapy | Body Composition Changes | Mediterranean DietItaly
-
National Institute of Diabetes and Digestive and...RecruitingHealthy Volunteers | Diet TherapyUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Beneo-InstituteGerman Sport University, CologneNot yet recruitingDietary Habits | Diet, Healthy | Sports Physical Therapy
-
University of Maryland, BaltimoreNational Center for Advancing Translational Sciences (NCATS)Active, not recruitingNeoplasms | Fatigue | Time | Therapy | Diet Therapy | Survivorship | Fasting, IntermittentUnited States
-
University of DelawareCompletedDiet, Healthy | Autonomic Nervous System | Affect | Nutrition Therapy | DieteticsUnited States
-
University of NottinghamNottingham University Hospitals NHS Trust; University Hospitals of Derby and...Not yet recruitingDiet | Dialysis | Diet Therapy | Protein Intake | High Protein Dietary Intake | Protein Energy Wasting | Muscle Mass | Hospitalisation | Muscle Mass and Strength | Dialysis PatientsUnited Kingdom
-
Baskent UniversityCompletedDiet Therapy | Immunoglobulin A | Cow Milk Protein Allergy | MucinTurkey (Türkiye)
-
Zealand University HospitalVIA University College; Steno Diabetes Center Sjaelland; The Danish Kidney Association and other collaboratorsEnrolling by invitationDiabetes | Nutritional Status | Dialysis | Diet TherapyDenmark
Clinical Trials on High Pasta
-
Sansum Diabetes Research InstituteHarvard UniversityCompleted
-
University of MinnesotaCompleted
-
Clinical Nutrition Research Center, Illinois Institute...Barilla America, Inc.Completed
-
Minneapolis Veterans Affairs Medical CenterCompletedMetabolic Syndrome | Type 2 Diabetes | Blood Glucose ConcentrationUnited States
-
University of BolognaEuropean CommissionUnknown
-
Arizona State UniversityInflammation Research FoundationCompletedInsulin Resistance
-
Federico II UniversityCompleted
-
Clinica Universidad de Navarra, Universidad de...CompletedPostprandial Glycemia | Resistant StarchSpain
-
University of BariCompletedIrritable Bowel Syndrome | Gluten Sensitivity
-
Maastricht University Medical CenterRecruitingGlucose Metabolism | Lipid MetabolismNetherlands